Pharmacological Review on Hridya Dasaimani in the Management of Hridroga (Cardiovascular diseases)
Keywords:Hridya, Hridya Dasaimani, Cardiovascular Diseases, Prophylactic, Cardioprotective
Cardiovascular disease is a major cause of disability and premature death throughout the world. The heart is the vital organ as any type of damage to this organ leads to loss of life. Several forms of therapies can prevent Coronary, Cerebral and peripheral Vascular events. Recommendations are made for the management of major Cardiovascular risk factors through a change in lifestyle and Prophylactic drug therapies. Hridya Mahakashaya as said by Charaka is a group of ten drugs that comprise mostly citrus fruits with Ascorbic acid in it. These drugs are useful in maintaining cardiac health. The Critical analysis of these drugs in the treatment of Hridroga indicates they have a crucial role in the management of cardiac as well as cerebrovascular diseases. Apart from cardio protective activity, some were also reported for their antioxidant, antihypertensive, anti-stress, anti-hyperlipidemic, antidiabetic, diuretic, antimicrobial and immunomodulatory activities. In this review, an attempt has been made to explain the Hridya action of Hridya Dasaimani in Ayurveda as well as modern aspect.
How to Cite
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.